Showing results (1191-1200 of 3,550) with videos related to

Sort By:
Pageof 355
Thoracic Cancer|May 8, 2020
Strategy for initial en bloc resection of a giant mediastinal solitary fibrous tumor: Judicious usage of cardiopulmonary bypassLei Chen, Yonghua Sang, Zhiwei Zhang, et al.
Thoracic Cancer|May 8, 2020
Does the length of uniportal video-assisted thoracoscopic lobectomy affect postoperative pain? Results of a randomized controlled trialCecilia Menna, Camilla Poggi, Claudio Andreetti, et al.
Thoracic Cancer|May 8, 2020
Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclolYan'e Liu, Jie Zhang, Zhongnan Yin, et al.
Thoracic Cancer|May 16, 2020
Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CAXuerui Li, Xiaoqing Chen, Lingzhu Wen, et al.
Thoracic Cancer|May 17, 2020
Metachronous primary lung adenocarcinomas harboring distinct KRAS mutationsYan Hu, Siying Ren, Chen Chen, et al.
Thoracic Cancer|March 28, 2023
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastasesChi-Lu Chiang, Hsiang-Ling Ho, Yi-Chen Yeh, et al.
Thoracic Cancer|April 15, 2020
Lung immune prognostic index as a prognostic factor in patients with small cell lung cancerKei Sonehara, Kazunari Tateishi, Masamichi Komatsu, et al.
Thoracic Cancer|April 16, 2020
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancerTadashi Sakaguchi, Naoki Furuya, Kentaro Ito, et al.
Thoracic Cancer|April 16, 2020
First-line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD-L1: A case reportKosuke Hamai, Hiroki Tanahashi, Sayaka Ueno, et al.
Thoracic Cancer|April 16, 2020
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemicZhe Zhao, Hua Bai, Jianchun Duan, et al.
Pageof 355